Trial Profile
Predictive Factors of Persistence in Therapy with Abatacept in Patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 02 Feb 2016 New trial record
- 01 Dec 2014 Recruitment completed according to results presented at the 17th Annual Congress of the European League Against Rheumatism